Mednet Logo
CommunityDermatology

How would you manage subclinical ILD associated with MDA-5 Dermatomyositis?

Any indications for triple therapy in the patients with subclinical ILD associated with MDA-5 dermatomyositis?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Rheumatology · University of Pittsburgh
Answered on

Subclinical ILD in anti-MDA5 is like a time bomb waiting to explode. Would do aggressive monitoring for ILD symptoms/tests and give at least 1st line immunosuppression with CellCept or tacrolimus.

Join for free or sign in to see the full answer